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Historic review  - ActiGait – a new FES (Functional Electrical Stimulation) 
improves gait among patients with apoplectic hemiplegia. 
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Background: In 1999 the first ActiGait system was created at Aalborg University by 
prof. Thomas Sinkjaer and Morten Haugland PhD (Sinkjaer et al. Exp Brain Res 
1994). Neurodan was in 2005 bought by the Otto Bock Group and a new series of 
ActiGait-implantations were initiated in Europe (Burridge et al. J.Rehabil Med. 2007).                                                                                                        
For neurosurgeons walking seems to be a trivial and simple motor-function – but is 
not (Sinkjaer et al. 1994, Spaich et al. Exp Brain Res 2009). Walking implies precise 
coordination between legs, arms and body. Sensory input from tendons/and skin are 
important for the posture and balance during walking. Besides the brain directed 
walking system, a spinal cord automatic system is thus necessary for the walking 
(Franceschini et al. Stroke 2009). The ActiGait system serves as an instrument to 
change the plantar positioned foot (pronated and plantar flexed) found among many 
hemiplegics into one with a dynamic dorsiflexion. Thereby it changes the walking 
pattern significantly. We assume this is partly through reflex modulation (Spaich et al. 
2009). Automatic within-step sensory feedback regulation and not conscious 
predictive control is the most important factor for achieving a stable walking  (Klint R 
af et al. J Physiol  2008) Our patient’s claims that they feel safer when walking, and 
they participate in daily life in a much more independent and secure way than before. 
It is thus not only the speed of walking that increases, but perhaps mostly it is the 
balance that is improved. 
Results: The first operated series consisted of 15 ActiGait system implantations 
treating patients with stable hemiparesis due to vascular brain lesions. This series 
were carried out in Denmark as a phase 2 trial with. All patients benefitted and there 
were no nerve injuries based on clinical examination and electrophysiological 
validation. (Burridge et al.2007). It must be noted that among our first operated 
patients, 8 survivors still uses the system today with success. In the summer 2007 
further six patients were operated upon in Germany and Denmark. Due to internal 
wire problems the operations were stopped. After the first cases operated upon in 
Europe since august 2008, we realized - to our surprise - two severe peroneal nerve 
lesions. The project was therefore halted until a thorough review and validation had 
been undertaken within the Otto Bock Group. In this we included validation of 
biomechanics related to the ActiGait system and MRI scanning of the tissue in the 
knee region. Since July 2009 – a further 18 cases have been operated upon in 
Denmark, Germany, the Netherlands, Luxembourg, Austria and Romania, all awaiting 
long term follow up’s before results are being published.                                                                     
Animations of patients walking without and with ActiGait systems illustrates our 
results.  
